TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10178675

Group type: EXPERIMENTAL
Intervention: Belgian blood donors
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tunisian blood donors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both populations
Number of subjects: 0
Study: 7678844

Group type: EXPERIMENTAL
Intervention: Carbon monoxide exposure (3% COHb)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Carbon monoxide exposure (5% COHb)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Room air (control)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 33
Study: 3301455

Group type: EXPERIMENTAL
Intervention: 0.25% desoxymethasone
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: 0.05% desoxymethasone
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: 0.1% betamethasone valerate
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: 1% hydrocortisone
Number of subjects: 96
Study: 29431561

Group type: EXPERIMENTAL
Intervention: Respiratory muscle training
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Peripheral muscle training
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 37
Study: 26826274

Group type: EXPERIMENTAL
Intervention: Sequential media (Quinn's Advantage Cleavage Medium followed by Blast Assist)
Number of subjects: 192

Group type: COMPARATOR
Intervention: Monophasic medium (Continuous Single Culture)
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Sequential media
Number of subjects: 192

Group type: COMPARATOR
Intervention: Monophasic medium
Number of subjects: 192
Study: 25532586

Group type: EXPERIMENTAL
Intervention: Low-dose Saccharum iron (200 mg/dose, once a week for 5 weeks, total 1000 mg)
Number of subjects: 38

Group type: COMPARATOR
Intervention: High-dose Saccharum iron (500 mg/dose, once every two weeks for 4 weeks, total 1000 mg)
Number of subjects: 38
Study: 24324379

Group type: EXPERIMENTAL
Intervention: Virtual reality-cognitive rehabilitation (VR-CR) intervention
Number of subjects: 4

Group type: COMPARATOR
Intervention: Control test
Number of subjects: 4
Study: 20634296

Group type: EXPERIMENTAL
Intervention: Urinary Albumin Excretion (UAE)
Number of subjects: 701

Group type: EXPERIMENTAL
Intervention: Urinary Protein Excretion (UPE)
Number of subjects: 701

Group type: EXPERIMENTAL
Intervention: Urinary Albumin Concentration (UAC)
Number of subjects: 701

Group type: EXPERIMENTAL
Intervention: Albumin:Creatinine Ratio (ACR)
Number of subjects: 701
Study: 18340485

Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP)
Number of subjects: 1256

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1256
Study: 16888046

Group type: EXPERIMENTAL
Intervention: ISC+EX (ischemia with low-intensity exercise)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: ISC (ischemia alone)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 9
Study: 12807386

Group type: EXPERIMENTAL
Intervention: Lamotrigine (LTG) 300 mg daily
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 11137977

Group type: EXPERIMENTAL
Intervention: Swimming in water at 29 degrees C
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Swimming in water at 36 degrees C
Number of subjects: 19

Group type: COMPARATOR
Intervention: Swimming in water at 29 degrees C vs 36 degrees C (non-trained subjects)
Number of subjects: 19
Study: 8841799

Group type: EXPERIMENTAL
Intervention: Various gestational ages and umbilical artery Doppler flow velocity waveforms or CTG variability measures
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Randomized trials of management
Number of subjects: 49
Study: 1738415

Group type: EXPERIMENTAL
Intervention: Calcium acetate (Ca Ac)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Calcium carbonate (CaCO3)
Number of subjects: 8
Study: 6322906

Group type: EXPERIMENTAL
Intervention: 20 days treatment with sodium stibogluconate
Number of subjects: 126

Group type: COMPARATOR
Intervention: More than 20 days treatment with sodium stibogluconate if necessary
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Pentamidine (for non-responders)
Number of subjects: 126

Group type: COMPARATOR
Intervention: More than 20 days treatment with sodium stibogluconate
Number of subjects: 126
Study: 31480895

Group type: EXPERIMENTAL
Intervention: Trained coaches' practices
Number of subjects: 76

Group type: COMPARATOR
Intervention: Untrained coaches' practices
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Games with trained coaches
Number of subjects: 76

Group type: COMPARATOR
Intervention: Free time
Number of subjects: 76
Study: 29407500

Group type: EXPERIMENTAL
Intervention: 0.0175‐in 6‐strand stainless steel wire
Number of subjects: 120

Group type: COMPARATOR
Intervention: 0.0195‐in dead‐soft coaxial wire
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Second group (0.0195‐in dead‐soft coaxial wire)
Number of subjects: 120
Study: 26984429

Group type: EXPERIMENTAL
Intervention: Triple-contrast multi-detector computed tomography (CT)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 171
Study: 24642339

Group type: EXPERIMENTAL
Intervention: Clinical decision support system providing un‐intrusive feedback for automatically verifiable rules (specific inter‐related subset of rules)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clinical decision support system providing un‐intrusive feedback for non‐automatically verifiable rules (feedback framed as actions with positive consequences)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clinical decision support system providing un‐intrusive feedback for non‐automatically verifiable rules (feedback framed as inaction with negative consequences)
Number of subjects: 0
Study: 22079603

Group type: EXPERIMENTAL
Intervention: Levonorgestrel (LNG)-containing combination oral contraceptives
Number of subjects: 181
Study: 19623693

Group type: EXPERIMENTAL
Intervention: Dapivirine matrix IVR
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Dapivirine reservoir IVR
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo IVR
Number of subjects: 24
Study: 17890954

Group type: EXPERIMENTAL
Intervention: Ultrahigh-dose streptokinase (UH-SK n = 8)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Alteplase (tPA n = 7)
Number of subjects: 15
Study: 14981602

Group type: EXPERIMENTAL
Intervention: Continuous venovenous hemofiltration (CVVH) with an ultrafiltration rate of 1 L/h
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Continuous venovenous hemofiltration (CVVH) with an ultrafiltration rate of 2.5 L/h
Number of subjects: 24

Group type: COMPARATOR
Intervention: Continuous venovenous hemodialysis (CVVHD) with a dialysate flow rate of 1 L/h
Number of subjects: 24

Group type: COMPARATOR
Intervention: Continuous venovenous hemodialysis (CVVHD) with a dialysate flow rate of 2.5 L/h
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Increasing ultrafiltration volume or dialysate flow
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 2.5-L/h hemofiltration mode
Number of subjects: 24
Study: 11782981

Group type: EXPERIMENTAL
Intervention: Intravenous thrombolysis with tissue plasminogen activator
Number of subjects: 19

Group type: COMPARATOR
Intervention: Historical control group of 21 sub-6-hour ischemic stroke patients
Number of subjects: 19
Study: 9653702

Group type: EXPERIMENTAL
Intervention: Danazol (400 mg/d orally for 12 weeks)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Control group (no treatment, next IVF-ET performed within six months after previous failed cycle)
Number of subjects: 81
Study: 8138680

Group type: EXPERIMENTAL
Intervention: E5 (edobacomab) 1 mg/kg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: E5 (edobacomab) 2 mg/kg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: E5 (edobacomab) 4 mg/kg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: E5 (edobacomab) all doses
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: E5 (edobacomab) 1 mg/kg and 4 mg/kg
Number of subjects: 10
Study: 2817961

Group type: EXPERIMENTAL
Intervention: Respiratory valve with facemask and noseclip
Number of subjects: 6

Group type: COMPARATOR
Intervention: Mouthpiece without facemask
Number of subjects: 6
Study: 30446161

Group type: EXPERIMENTAL
Intervention: Intraperitoneal bupivacaine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 0
Study: 27920119

Group type: EXPERIMENTAL
Intervention: Telephone coaching by a family physician (twice a month)
Number of subjects: 161

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 161
Study: 25216712

Group type: EXPERIMENTAL
Intervention: Linseed oil (α-linolenic acid; 7 g ALA/day)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Echium oil (stearidonic acid; 2 g SDA/day)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Microalgae oil (docosahexaenoic acid; 2 g DHA/day)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Sunflower oil (linoleic acid; 10 g LA/day)
Number of subjects: 59
Study: 23431993

Group type: EXPERIMENTAL
Intervention: 25‐mg meperidine
Number of subjects: 140
Study: 22080314

Group type: EXPERIMENTAL
Intervention: Creatine supplementation (4 × 5 g Cr monohydrate per day)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo supplementation (4 × 5 g maltodextrin per day)
Number of subjects: 27
Study: 19300274

Group type: EXPERIMENTAL
Intervention: Sedation
Number of subjects: 1126

Group type: COMPARATOR
Intervention: No Sedation
Number of subjects: 1126
Study: 17012044

Group type: EXPERIMENTAL
Intervention: Bilateral oophorectomy before age 45 years
Number of subjects: 4780

Group type: EXPERIMENTAL
Intervention: Unilateral oophorectomy
Number of subjects: 4780

Group type: COMPARATOR
Intervention: Referent women (no oophorectomy)
Number of subjects: 4780
Study: 14704798

Group type: EXPERIMENTAL
Intervention: Intermittent static dorsiflexion at 50% MVC with leg elevated
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intermittent static dorsiflexion at 50% MVC with leg down
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intermittent static dorsiflexion with occluded muscle blood flow
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intermittent static dorsiflexion without occluded muscle blood flow
Number of subjects: 0
Study: 11421189

Group type: EXPERIMENTAL
Intervention: Supervised physical therapy rehabilitation (one hour, twice weekly) with emphasis on balance training
Number of subjects: 92

Group type: COMPARATOR
Intervention: Standard information about early ankle mobilisation (Control group)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Both training and control groups
Number of subjects: 92
Study: 9402175

Group type: EXPERIMENTAL
Intervention: Second-line treatment for relapsing patients
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Age > 60 at diagnosis
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Number of chemotherapy cycles > 6
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Age > 60
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Chest radiotherapy
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Absence of relapse
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Overall survival rates
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Return to work
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Therapeutic sequelae
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Physical, mental, and psychological states
Number of subjects: 263
Study: 8273321

Group type: EXPERIMENTAL
Intervention: Solcoseryl
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: DuoDerm
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control treatment (Eusol)
Number of subjects: 32
Study: 2485043

Group type: EXPERIMENTAL
Intervention: Perindopril (dose titration of 2, 4, 6, and 8 mg once daily)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 30541474

Group type: EXPERIMENTAL
Intervention: Yoga (60-min sessions, 2x weekly for 10 weeks)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Health education (90-min sessions, weekly for 10 weeks)
Number of subjects: 46
Study: 27383312

Group type: EXPERIMENTAL
Intervention: Organic melon (250 g per day for 15 days)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Market melon (250 g per day for 15 days)
Number of subjects: 53
Study: 24006357

Group type: EXPERIMENTAL
Intervention: IQP-PV-101
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study: 22750359

Group type: EXPERIMENTAL
Intervention: Hypermedia instruction
Number of subjects: 84

Group type: COMPARATOR
Intervention: Traditional instruction
Number of subjects: 84
Study: 20051299

Group type: EXPERIMENTAL
Intervention: Sitagliptin plus G-CSF
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 100
Study: 18588694

Group type: EXPERIMENTAL
Intervention: 400 mg of albendazole every 2 months over a year
Number of subjects: 68

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 68
Study: 16230562

Group type: EXPERIMENTAL
Intervention: 5-aminolevulinic acid (5-ALA) pretreatment followed by intense pulsed light (IPL) treatment
Number of subjects: 20

Group type: COMPARATOR
Intervention: IPL treatment alone
Number of subjects: 20
Study: 11851783

Group type: EXPERIMENTAL
Intervention: Nurse-administered 'side-effect' checklists
Number of subjects: 40

Group type: COMPARATOR
Intervention: No intervention (comparator group)
Number of subjects: 40
Study: 10094243

Group type: EXPERIMENTAL
Intervention: Epinephrine
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 7757133

Group type: EXPERIMENTAL
Intervention: Tamoxifen 20 mg/day for 5 years
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo for 5 years
Number of subjects: 0
Study: 2253903

Group type: EXPERIMENTAL
Intervention: 300 ml radiolabelled beef consommé with 60 g margarine
Number of subjects: 7

Group type: COMPARATOR
Intervention: 300 ml radiolabelled beef consommé without margarine
Number of subjects: 7
Study: 6244611

Group type: EXPERIMENTAL
Intervention: Rheumajecta
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 31067706

Group type: EXPERIMENTAL
Intervention: Metformin (MET)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Both MET and Placebo
Number of subjects: 165
Study: 28822412

Group type: EXPERIMENTAL
Intervention: Han-uvulopalatopharyngoplasty with septoplasty (study group)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Han-uvulopalatopharyngoplasty (control group)
Number of subjects: 96
Study: 26900936

Group type: EXPERIMENTAL
Intervention: Diazepam (10 mg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 24090116

Group type: EXPERIMENTAL
Intervention: Staple wound closure
Number of subjects: 340

Group type: COMPARATOR
Intervention: Suture wound closure
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: African-American race
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: Body mass index ≥30
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: Diabetes mellitus
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: Composite wound morbidity (disruption or infection)
Number of subjects: 340
Study: 21933835

Group type: EXPERIMENTAL
Intervention: AeroChamber Plus with Facemask
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Babyhaler
Number of subjects: 17

Group type: COMPARATOR
Intervention: Babyhaler/AeroChamber Plus
Number of subjects: 17
Study: 19888488

Group type: EXPERIMENTAL
Intervention: Real acupuncture
Number of subjects: 28

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 28
Study: 18158675

Group type: EXPERIMENTAL
Intervention: Integrated course of physical examination and trunk anatomy (5 small group sessions)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Integrated course of physical examination and trunk anatomy
Number of subjects: 39

Group type: COMPARATOR
Intervention: Routine anatomy lectures and problem based learning discussions
Number of subjects: 39
Study: 17143713

Group type: EXPERIMENTAL
Intervention: Intracoronary brachytherapy
Number of subjects: 1310

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1310
Study: 12783373

Group type: EXPERIMENTAL
Intervention: Imatinib 400 mg daily
Number of subjects: 1106

Group type: COMPARATOR
Intervention: IFN up to 5 MU/m(2)/d with cytarabine (Ara‐C) 20 mg/m(2)/d for 10 days every month
Number of subjects: 1106

Group type: EXPERIMENTAL
Intervention: Imatinib after crossover from IFN
Number of subjects: 1106

Group type: EXPERIMENTAL
Intervention: Imatinib
Number of subjects: 1106

Group type: COMPARATOR
Intervention: IFN
Number of subjects: 1106
Study: 10382693

Group type: EXPERIMENTAL
Intervention: Therapeutic NCPAP
Number of subjects: 107

Group type: COMPARATOR
Intervention: Subtherapeutic NCPAP
Number of subjects: 107
Study: 8926345

Group type: EXPERIMENTAL
Intervention: TX11323(A) gel
Number of subjects: 48

Group type: COMPARATOR
Intervention: Reference gel
Number of subjects: 48
Study: 2057701

Group type: EXPERIMENTAL
Intervention: 0.5 mg of human calcitonin
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: 100 IU of salmon calcitonin
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 49
Study: 7051464

Group type: EXPERIMENTAL
Intervention: 1 unit of packed red cells (mean of 2350 x 10(6) leukocytes, 900 x 10(6) mononuclear cells) 3 times at 15-day intervals
Number of subjects: 65

Group type: COMPARATOR
Intervention: One transfusion of about 30 ml of blood adjusted to contain 100 x 10(6) mononuclear cells
Number of subjects: 65
Study: 31872349

Group type: EXPERIMENTAL
Intervention: Clopidogrel 75 mg daily
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Clopidogrel 75 mg daily plus rivaroxaban 2.5 mg twice daily
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Ticagrelor 90 mg twice daily
Number of subjects: 150
Study: 30935897

Group type: EXPERIMENTAL
Intervention: Norepinephrine
Number of subjects: 123

Group type: COMPARATOR
Intervention: Phenylephrine
Number of subjects: 123
Study: 28829155

Group type: EXPERIMENTAL
Intervention: Ashwagandha root extract (600 mg daily)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo (starch)
Number of subjects: 50
Study: 27348483

Group type: EXPERIMENTAL
Intervention: Ledipasvir/sofosbuvir plus ribavirin for 8 weeks
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Ledipasvir/sofosbuvir plus GS-9669 250 mg for 8 weeks
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Ledipasvir/sofosbuvir plus GS-9669 500 mg for 8 weeks
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Ledipasvir/sofosbuvir plus vedroprevir ± ribavirin for 8 weeks
Number of subjects: 146
Study: 25102686

Group type: EXPERIMENTAL
Intervention: Busuishengxue granules
Number of subjects: 60

Group type: COMPARATOR
Intervention: Zaizaoshengxue tablets
Number of subjects: 60
Study: 22350730

Group type: EXPERIMENTAL
Intervention: Providing young orphan adolescents with uniforms, school fees, and community visitors
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Volunteer community visitors
Number of subjects: 105
Study: 19413731

Group type: EXPERIMENTAL
Intervention: Nonleukoreduced PLT concentrates stored at 20 to 24°C for up to 7 days
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Leukoreduced PLT pools
Number of subjects: 40
Study: 17665247

Group type: EXPERIMENTAL
Intervention: Traditional lateral internal sphincterotomy (up to the dentate line)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Conservative internal anal sphincterotomy (up to the height of the fissure apex)
Number of subjects: 108
Study: 15786529

Group type: EXPERIMENTAL
Intervention: Folic acid 10 mg thrice daily
Number of subjects: 38

Group type: COMPARATOR
Intervention: Sucralfate 1,000 mg thrice daily
Number of subjects: 38
Study: 12088306

Group type: EXPERIMENTAL
Intervention: Methylphenidate 0.3 mg/kg, twice daily
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Methylphenidate 0.5 mg/kg, twice daily
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study: 9682182

Group type: EXPERIMENTAL
Intervention: Modafinil (300 mg x 2) during sleep deprivation (N1)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo during sleep deprivation (N1)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Modafinil (300 mg x 2) and Placebo during recovery and control nights (N2)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Modafinil (300 mg x 2) and Placebo during sleep deprivation (N1)
Number of subjects: 8
Study: 7878164

Group type: EXPERIMENTAL
Intervention: Caffeine (2.5 mg/kg bodyweight)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Smoking (1.2 mg nicotine yield from cigarette with 8 cued puffs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 2304216

Group type: EXPERIMENTAL
Intervention: Blinded peer review (authors' and institutions' names removed)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Non-blinded peer review (authors' and institutions' names included)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Signing reviews
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Quality association with signing
Number of subjects: 127
Study: 41543

Group type: EXPERIMENTAL
Intervention: Temazepam 15 mg (short-term study)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Temazepam 30 mg (long-term study)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 29777527

Group type: EXPERIMENTAL
Intervention: Training with premovement cues that allowed for preparatory movement planning
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Incidental training to reduce explicit skill knowledge
Number of subjects: 0
Study: 28257159

Group type: EXPERIMENTAL
Intervention: MEDIAS 2 BSC
Number of subjects: 182

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 182
Study: 26452366

Group type: EXPERIMENTAL
Intervention: Educational and social worker intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Educational and social worker intervention plus financial assistance program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care while on the transplant waiting list
Number of subjects: 0
Study: 22882353

Group type: EXPERIMENTAL
Intervention: Oral cholecalciferol (300,000 IU in six divided doses over 3 months)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Intramuscular cholecalciferol (300,000 IU as a single injection)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Both treatment regimens
Number of subjects: 92